Table 1.
The comparative pre- operative data from the patients both groups.
| Group A | Group B | p | |
|---|---|---|---|
| General characteristics | |||
| Number of patients | 25 | 25 | - |
| Male/female | 20/5 | 21/4 | 1 |
| Age (y/s) | 66 ± 13 | 62 ± 15 | 0,319 |
| Height (cm) | 164 ± 9 | 168 ± 11 | 0,166 |
| Weight (kg) | 75 ± 11 | 72 ± 8 | 0,276 |
| BSA | 1.74 ± 7.4 | 1.82 ± 6.6 | 0,968 |
| Clinical preoperative data | |||
| Hypertension | 16 | 14 | 0.773 |
| Diabetes mellitus | 8 | 10 | 0.769 |
| Euroscore | 4.8 ± 2.2 | 4.5 ± 2.6 | 0,662 |
| 3-coronary vessel disease | 19 | 17 | 0.754 |
| 2-coronary vessel disease | 6 | 9 | 0.538 |
| Significant Left main CAD | 2 | 4 | 0.667 |
| Ischemic mitral regurgitation 1+/4+ | 7 | 4 | 0.496 |
| Ischemic mitral regurgitation 2+/4+ | 4 | 8 | 0.321 |
| Ejection fraction 30-35% | 9 | 12 | 0.567 |
| Ejection fraction 35-40% | 16 | 13 | 0.567 |
| Cardiac Index (L/min/m2) | 3.1 ± 0,6 | 3.2 ± 0.8 | 0,619 |
| PCWP < 15 | 9 | 10 | 0.773 |
| PCWP > 15 | 16 | 15 | 0.773 |
| Preoperative medication | |||
| aMEA | 25 | 25 | - |
| b-blockers | 14 | 17 | 0.377 |
| Calcium channel blockers (pts) | 11 | 8 | 0.561 |